Watching Now: Nasdaq Profile (INBS) Pops Green On Breaking News (Strong Financial Results)

*Sponsored


Watching Now: Nasdaq Profile (INBS) Pops Green On Breaking News (Strong Financial Results)


May 13th

Greetings, Friend!


Intelligent Bio Solutions Inc. (Nasdaq: INBS) is making moves early Tuesday.


Popping green first thing, INBS could start attracting some serious buzz after dropping breaking news!


Take a look:


Intelligent Bio Solutions Announces Fiscal Q3 2025 Financial Results and Key Operational Achievements


20% sequential quarterly revenue growth and 91% year-over-year quarterly gross pro-fit growth


Continued momentum from recurring higher-margin cartridge sales now reaching 58% of total sales for the nine months ended March 31, 2025


35 new accounts and international growth during Q3 bring total active accounts to over 450


NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced its financial results for the fiscal third quarter and nine months ended March 31, 2025, and provided a business update.


The Company delivered a strong quarter of growth in revenue compared to the previous quarter, supported by ongoing expansion across safety-critical industries and steady customer acquisition. Cartridge sales, a key contributor to margin improvement, continue to make up a growing share of income, contributing 58% of total revenue for the fiscal year to March 31, 2025, and strengthening the Company’s recurring revenue model. With 35 new customers added during the quarter and an active customer base now surpassing 450 accounts, INBS remains on track with its plans to scale its commercial footprint and international presence ahead of its expected entry into the U.S. market.


...


As we expand further into new markets, our focus on growing cartridge adoption, our highest-margin revenue stream, is strengthening the business fundamentals,said Harry Simeonidis, President and CEO at Intelligent Bio Solutions.We’ve also seen a notable reduction in losses this quarter, reflecting ongoing improvements in cost control and operational efficiency. To support global scalability, we introduced multilingual functionality across our drug screening system and websites, ensuring our solution is widely accessible, commercially viable, and ready for broader distribution across international markets. We believe these efforts are laying a strong foundation for long-term, sustainable revenue growth.

...


Read the full article here.


Remember, INBS is a low float idea with roughly 4.72Mn shares.


That means it will be critical to watch for potential volatility after today's huge announcement.


Don't hesitate. Consider (Nasdaq: INBS) for your watchlist and check out my initial report below right now.

-----


Let's rewind to this past Friday in case you weren't around...


Pay close attention-because the action with my latest Nasdaq profile was nothing short of electrifying.


Following Thursday’s after-hours close of $.54, that sizzler rocketed to a Friday high of $.8138, setting the market abuzz.


We’re talking about a lightning-fast surge of approx. 50% in a matter of hours-an explosive move that left profile trackers looking for more.


But here’s where it gets even more exciting: I’ve got my eye on a brand-new, under-the-radar profile.


With a low float of fewer than 5Mn shares, a $12 analyst target suggesting over 850% potential upside from Monday's close, and massive May news, this Nasdaq profile may start earning Wall Street's immediate attention.


Consider taking a look at: Intelligent Bio Solutions Inc. (Nasdaq: INBS)


Intelligent Bio Solutions Inc. is rapidly emerging as a leader in the medical technology sector, pioneering non-invasive, real-time point-of-care testing solutions that are reshaping how drug screening and diagnostics are conducted worldwide.


With a focus on pain-free, accessible, and accurate testing, the company is positioned at the forefront of a global movement toward more humane and efficient healthcare technologies.


Company Overview


Founded in 2016 and headquartered in New York, Intelligent Bio Solutions Inc. is committed to leveraging advanced technology to develop transformative solutions that improve quality of life.


The company’s mission is to redefine the approach to testing by delivering pain-free, accessible solutions that drive transformative change across healthcare and workplace safety.


Core Technologies and Products


Intelligent Fingerprinting Drug Testing Solution


At the heart of INBS’s innovation is the Intelligent Fingerprinting Drug Testing Solution.


This system utilizes a patented technology that analyzes sweat collected from the fingertips to detect recent drug use-including cann-a-bis, co-caine, o-piate-s, and me-thamp-heta-mine-within the preceding 16–24 hours.


The process is non-invasive, requiring less than a minute for sample collection and delivering results in under ten minutes.


Key advantages include:


  • Dignified, Non-Invasive Collection: No need for blood, urine, or saliva samples, reducing discomfort and privacy concerns.


  • Rapid Results: Enables timely decision-making in workplace, clinical, and law enforcement settings.


  • Portability and Ease of Use: Designed for use in the field, workplaces, and clinics, with minimal training required.


  • Hygienic and Cost-Effective: Reduces biohazard risks and maintenance costs, with annual calibration sufficing for ongoing use.


Regulatory Milestones And U.S. Market Entry


A significant milestone was achieved with the submission of the FDA 510(k) pre-market notification for the Intelligent Fingerprinting Drug Screening System in December 2024.


The company’s clinical studies have demonstrated high sensitivity, specificity, and usability, with performance data showing 94.1% accuracy and pharmacokinetic studies confirming the reliability of fingerprint sweat as a matrix for drug detection.


INBS is on track for a planned expansion into the multi-Bn dollar U.S. market in 2025, targeting a region that accounts for approximately 28% of the global drug screening market.


The rising rates of drug positivity in the U.S. workforce-particularly in safety-sensitive industries-underscore the urgent need for effective, rapid, and non-invasive testing solutions like those offered by INBS.


Intellectual Property and Competitive Position


INBS’s technology is protected by a robust intellectual property portfolio, including six U.S. patents covering the lateral flow test strip, sample collection cartridge, cartridge housing, and buffer clip design.


This IP protection strengthens the company’s competitive position as it prepares for broader commercialization and future product development.


Market Opp. And Future Outlook

Why Take A Closer Look?


Intelligent Bio Solutions Inc. stands out for several compelling reasons:


Innovative, Patented Technology: Non-invasive, rapid, and highly accurate testing solutions with strong IP protection.


Proven Market Acceptance: Operational in 19 countries with a growing base of over 450 customer accounts.


Strong Financial Trajectory: Demonstrated revenue and margin growth, with a scalable, recurring revenue model.


Strategic Global Expansion: Active in high-growth markets and sectors, with multilingual capabilities and key partnerships.


Clear Path to U.S. Market: On track for potential FDA clearance and entry into the world’s largest drug screening market in 2025.


Vision for Broader Diagnostics: Versatile biosensor platform poised for future applications in clinical diagnostics.

-----


Three (3) Immediate (Nasdaq: INBS) Potential Catalysts To Consider


#1. A low float - INBS has a float of roughly 4.72Mn shares.


This means volatility potential may be heightened on a daily basis.


#2. An analyst $12 target - As of May 12th, Ladenburg Thalmann Co. Inc. was reporting a $12 target on INBS.


From its closing valuation on Monday, that target is suggesting INBS to have over 850% potential upside.


#3. Major news this month - Intelligent Bio Solutions has launched new localized websites in Arabic, Italian, and Spanish to support its global expansion strategy, unlocking commercial access to regions representing over 1.4Bn people across Europe, the Middle East, and Latin America.

-----


Intelligent Bio Solutions Inc. (Nasdaq: INBS) is not just a company to watch-it is a transformative force in the medical technology landscape, delivering solutions that meet urgent global needs for rapid, reliable, and dignified testing.


Coverage is officially initiated on Intelligent Bio Solutions Inc. (Nasdaq: INBS). Keep an eye out for updates soon.


All the best,

Dane James

Editor Market Pulse Today


Sources:

INBS Website

INBS Presentation


(Remember: St-ock Prices Could Be Significantly Lower Now From The Original Dates I Provided.)


*MarketPulseToday.com (“MarketPulseToday” or “MPT” ) is owned by Thousand Sun Media LLC, MPT is not responsible for its accuracy. Make sure to always do your own research and due diligence on any day and swing profile MPT brings to your attention. Any emojis used do not have a specific defined meaning, and may be used inconsistently. We do not provide personalized in-vest-ment advice, are not in-vest-ment advisors, and any profiles we mention are not suitable for all in-vest-ors.


Pursuant to an agreement between Thousand Sun Media LLC and TD Media LLC, Thousand Sun Media LLC has been hired for a period beginning on 05/12/2025 and ending on 05/13/2025 to publicly disseminate information about (INBS:US) via digital communications. Under this agreement, Thousand Sun Media LLC has been paid five thousand USD (“Funds”). These Funds were part of the funds that TD Media LLC received from a third party who did receive the Funds directly or indirectly from the Issuer and does not own st-ock in the Issuer but the reader should assume that the clients of the third party own shares in the Issuer, which they will liquidate at or near the time you receive this communication and has the potential to hurt share prices.


Neither Thousand Sun Media LLC, TD Media LLC and their member own shares of (INBS:US).


Please see important disclosure information here: https://marketpulsetoday.com/disclosure/inbs-hfnca/#details

Subscribe to receive free email updates:

0 Response to "Watching Now: Nasdaq Profile (INBS) Pops Green On Breaking News (Strong Financial Results)"

Post a Comment